AstraZeneca has completed all clinical studies required to support the first filings for the transition of its chronic ...

Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first ...

Budesonide 160mcg, glycopyrrolate 9mcg, formoterol fumarate 4.8mcg; per inhalation; metered-dose inhaler with dose counter ... each canister of Breztri Aerosphere is packaged in a foil pouch ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

AstraZeneca recently announced the completion of clinical studies for a next-generation propellant (NGP) version of its chronic obstructive pulmonary disease (COPD) inhaler, Breztri. This new ...

In the broader treatment landscape, competitors such as Areteia Therapeutics’ dexpramipexole, which has potential applications beyond eosinophilic asthma, and AstraZeneca’s Breztri ...

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, released its fourth annual TGaS Digital Marketing Competency ...

Associate Health Minister with responsibility for Pharmac David Seymour is pleased to see Pharmac continue to increase availability of medicines for Kiwis with the government’s largest ever investment ...